Trials / Completed
CompletedNCT03999086
Thromboelastography-Guided Fluid Management in Spinal Surgery
Thromboelastography-guided Fluid Management in Spinal Surgery: A Prospective Analysis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (actual)
- Sponsor
- Mayo Clinic · Academic / Other
- Sex
- All
- Age
- 18 Years – 89 Years
- Healthy volunteers
- Not accepted
Summary
The Researchers are trying to evaluate whether using a blood test called thromboelastogram (TEG) to manage patients undergoing multi-level spinal fusion surgery will reduce complications after surgery compared with the standard practices.
Detailed description
Multi-level instrumented spinal fusions represent an important treatment modality for degenerative scoliosis and sagittal malalignment. These surgeries remain a significant physiologic burden with high blood loss and long operative times. Thromboelastography provides a quantitative measure for blood product transfusion surrounding procedures. We aim to utilize thromboelastography to guide transfusions for multi-level spinal instrumentation. This two-arm, randomized, non-blinded prospective analysis will clarify reduced transfusion requirements for TEG-arm compared to non-TEG arm. We will also evaluate postoperative outcomes at the 1 year time-point.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Intervention | We will utilize thromboelastography to discern when to transfuse blood products in the setting of multi-level spinal fusion |
| OTHER | Control Group | Laboratory analysis to guide transfusion |
Timeline
- Start date
- 2018-01-12
- Primary completion
- 2019-11-08
- Completion
- 2019-11-08
- First posted
- 2019-06-26
- Last updated
- 2021-02-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03999086. Inclusion in this directory is not an endorsement.